Image (9cb1a2a0 B0ae 4825 A67a 31c42ef69edd 01)
Navitrux Injection, Powder, Lyophilized, For Solution
Product Images NDC 83831-153
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Navitrux (NDC 83831-153). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Avyxa Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Navitrux (fosaprepitant) For Injection, 150 mg/vial (Carton Label)
Navitrux (fosaprepitant) For Injection, 150 mg/vial (Container Label)
This is a description of a medication labeled as NDC 83831-153-01, featuring fosaprepitant for Injection. It comes in single-dose vials with 150 mg per vial. The medication is manufactured by Navitrex and distributed by Xyxa Pharma in New Jersey, USA. The recommended use is for Intravenous Infusion after reconstitution and dilution. The expiration date is listed as 05-2026. It is also mentioned that the product is made in China and any unused portion should be discarded.*
Image (9cb1a2a0 B0ae 4825 A67a 31c42ef69edd 140 2)
Image (Ce45271c 40ab 4ce2 B399 198cfb1253a5 136 1)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
